The European EIT Health program selected HeartGenetics as one of its most successful startups.
This Success Story has now been published on the EIT Health webpage https://www.eithealth.eu/-/heartgenetics.
Ana Teresa Freitas, Researcher at INESC-ID and CEO of Heartgenetics, explains why this merit award is so important for the startup:
“For Heartgenetics, being selected to participate in EIT Health GoEurope 2016, meant that we were awarded with a €50k grant that allowed us to fund a market study for evaluating the cardiovascular genetics market in Europe, which in turn enabled us to realign our strategy for European markets. The programme also gave us access to a greater network of Portuguese start-ups and entrepreneurs and access to EIT Health partners across Europe”.
EIT Health promotes healthy living, active ageing and improvements in healthcare by leveraging big data and new technologies, identifying and removing barriers to innovation, and building on education and talent creation.